PATENT CLAIM ANALYSIS

Application Number: 16096523
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to a pharmaceutical composition, particularly a modified release tablet composition comprising mirabegron or a pharmaceutically acceptable salt thereof and to a process for preparing such a composition.

Claim (Index 1):
A modified release tablet composition comprising:\n 1) 5 to 25 wt %, relative to the total weight, of a therapeutically effective dose of mirabegron or a pharmaceutically acceptable salt thereof; 2) 15 to 40 wt %, relative to the total weight, of a mixture of one or more polyethylene oxides, the mixture having a viscosity of 100 to 800 at a 2% aqueous solution at 25\u00b0 C.; and 3) a water insoluble hydrophilic excipient.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15730988', '10842809', '10843005', '14352785', '13073677']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6758511208680162
- 35 USC 102 Novelty (BERT): 0.4984593919682301
- Combined Prediction Score: 0.6581119479780376
- Mean Citation Score: 213.84979600000003
- Max Citation Score: 266.375
- Similarity Product: 233.54116728901863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test